Reduced P-AMPK expression is a frequent event in PDAC and correlated with poor prognosis and the dense stromal reaction. Metformin induced AMPK activation in pancreatic cancer cells leads to reduced production of fibrogenic cytokines. Metformin enhances the antitumor effect of gemcitabine.